FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/07/071316 [Registered on: 25/07/2024] Trial Registered Prospectively
Last Modified On: 25/07/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Clinical study to see the effect of eladi choorna by oral route in white discharge in females  
Scientific Title of Study   A Randomised Controlled Clinical Trial To Study The Effect Of Eladi Choorna Orally In Kaphaj Yonivyapad With Special Reference To Vulvovaginal Candidiasis. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Riddhi Vijay Kadav 
Designation  PG student 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Prasuti tantra avum Streeroga SMBT Ayurved College and Hospital Dhamangaon Nashik

Nashik
MAHARASHTRA
422403
India 
Phone  9820311379  
Fax    
Email  riddhikadav1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sameer S Gholap 
Designation  Professor 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Prasuti tantra avum Streeroga SMBT Ayurved College and Hospital Dhamangaon Nashik

Nashik
MAHARASHTRA
422403
India 
Phone  9820304881  
Fax    
Email  drsameer.gholap@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Riddhi Vijay Kadav 
Designation  PG student 
Affiliation  SMBT Ayurved College and Hospital 
Address  Department of Prasuti tantra avum Streeroga SMBT Ayurved College and Hospital Dhamangaon Nashik

Nashik
MAHARASHTRA
422403
India 
Phone  9820311379  
Fax    
Email  riddhikadav1997@gmail.com  
 
Source of Monetary or Material Support  
Department of Prasuti tantra avum Streeroga SMBT Ayurved College and Hospital Dhamangaon Nashik Maharashtra India 422403 
 
Primary Sponsor  
Name  Dr Riddhi Vijay Kadav 
Address  Department of Prasuti tantra avum Streeroga SMBT Ayurved College and Hospital Dhamangaon Nashik Maharashtra India 422403 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Riddhi Vijay Kadav  SMBT Ayurved College and Hospital  OPD No 4 Department of Prasuti tantra avum Streeroga Dhamangaon Nashik Maharashtra
Nashik
MAHARASHTRA 
09820311379

riddhikadav1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMBT Ayurved College and Hospital  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N760||Acute vaginitis. Ayurveda Condition: KAPAJA-YONIROGAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Eladi choorna, Reference: Vangsen Streerogadhikar/125, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 3 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
2Intervention ArmProcedure-yoni dhAvana, योनि धावन (Procedure Reference: yogratnakar, Procedure details: yonidhawan for 1-1.5 min once a day)
(1) Medicine Name: Guduchyadi kwath, Reference: yogratnakar yonivyapad chikitsa, Route: Vaginal, Dosage Form: Kwatha/Kashaya, Dose: 2000(ml), Frequency: od, Duration: 7 Days
3Comparator ArmProcedure-yoni dhAvana, योनि धावन (Procedure Reference: yogratnakar, Procedure details: yonidhawan for 1 -1.5 min once a day)
(1) Medicine Name: Guduchyadi kwath, Reference: Yogratnakar yonivyapad chikitsa , Route: Vaginal, Dosage Form: Kwatha/Kashaya, Dose: 2000(ml), Frequency: od, Duration: 7 Days
4Comparator ArmDrugClassical(1) Medicine Name: Pippalyadi choorna , Reference: Charak chikitsa, 30/84, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: tds, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: -lukewarm water), Additional Information: -
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  49.00 Year(s)
Gender  Female 
Details  married patients having sign and symptoms of kaphaj yonivyapad like Mild vaginal discharge Pruritis vulvae Dull pain 
 
ExclusionCriteria 
Details  Unmarried
Pregnant
Post natal women
known case of diabetes mellitus
Infections like HIV Syphilis Herpes genitalia 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
70  Baseline, 7th day 
 
Secondary Outcome  
Outcome  TimePoints 
Where the trial group stands in comparison with control group  18 months 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   05/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The prevalence rate of kaphaj yonivyapad (vulvovaginal candidiasis) is 22.3%. Due to wide use of antifungal agent developing resistance among reproductive female is the main problem. Ayurveda is best alternative for this as it helps to break the pathogenesis of disease. Ayurvedic treatment for management of kaphaj yonivyapad could be safe, effective, readily available, cost effective, non-invasive and without any side effect. For the management of kaphaj yonivyapad both oral and local medication with antifungal properties would have great impact. Chemical content of Eladi choorna shows antifungal properties against Candida albicans. Clinical trial to evaluate efficacy of Eladi choorna orally with local therapy of Yoni Dhawan with guduchyadi kwath would be beneficial to expand knowledge about management alternative. As clinical study has not been assessed in kaphaj yonivyapad so it will help to fill the knowledge gap. Including the married female patient having sign and symptoms of kaphaj yonivyapad like vaginal discharge, pruritis vulvae, dull pain between age group of 18-49 year who fulfill clinical diagnostic criteria. Written consent is taken from patient to ensure ethical compliance and transparency in research process. Sample size calculated is 35 each group by using formula by Daniel 1999. Simple random sampling technique will be used. Total 70 number of patients will be divided in two group named as Group A (trial group and Group B (control group).Eladi choorna orally and guduchyadi kwath locally for Yoni Dhawan to group A (Trial group), Pippalyadi choorna orally and guduchyadi kwath for Yoni Dhawan to group B (control group) will be given to patients. Drugs will be purchased from GMC certified pharmacy. Both drugs will be administered for 7 days. All SOP of choorna  preparation and Yoni Dhawan procedure will be followed throughout the clinical trial. Observation will be done on 0th and 7th day of treatment. Result will be drawn on basis of assessment criteria and statistical analysis. Discussion will be done on the basis of observation and result obtained during treatment. Summary will be drawn, and thesis work will be summarized with the help of statistical analysis. Conclusion will be drawn without bias. 
Close